In Brief: FDA On Disposable Wipes; Cosmetics Europe Appoints Director-General; More
This article was originally published in The Rose Sheet
FDA provides consumers with information on disposable wipes, their regulatory status, safe use and avenues for reporting adverse experiences with an April 7 update to its website. More news in brief.
You may also be interested in...
FDA could use data collected under the Toxic Substances Control Act to inform its risk-assessment work, a March 16 update indicates, announcing a memorandum of understanding between FDA and the Environmental Protection Agency. More news in brief.
The US Court of Appeals for the Federal Circuit has upheld a series of inter partes review decisions from 2017 in which three Humira patents were found invalid by the Patent Trial and Appeal Board within the US Patent and Trademark Office.